AbbVie Inc (ABBV)
171.70
+3.94
(+2.35%)
USD |
NYSE |
Nov 21, 16:00
171.73
+0.03
(+0.02%)
After-Hours: 17:03
AbbVie Price: 171.70 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 166.91 | 167.91 | 165.65 | 167.76 | 6.241M |
| Nov 19, 2024 | 165.27 | 167.10 | 163.81 | 166.57 | 5.246M |
| Nov 18, 2024 | 165.62 | 166.74 | 164.80 | 166.28 | 8.341M |
| Nov 15, 2024 | 169.63 | 169.63 | 164.72 | 164.99 | 11.27M |
| Nov 14, 2024 | 170.00 | 171.62 | 168.59 | 169.63 | 8.443M |
| Nov 13, 2024 | 171.67 | 172.64 | 169.65 | 170.35 | 8.483M |
| Nov 12, 2024 | 176.01 | 176.63 | 171.03 | 171.09 | 10.56M |
| Nov 11, 2024 | 178.22 | 178.57 | 172.70 | 174.43 | 20.76M |
| Nov 08, 2024 | 201.16 | 201.89 | 199.48 | 199.50 | 4.597M |
| Nov 07, 2024 | 201.95 | 202.32 | 199.22 | 200.51 | 4.520M |
| Nov 06, 2024 | 205.79 | 206.15 | 200.85 | 201.20 | 7.195M |
| Nov 05, 2024 | 200.49 | 202.42 | 198.35 | 201.68 | 5.109M |
| Nov 04, 2024 | 203.79 | 204.24 | 200.22 | 200.47 | 3.532M |
| Nov 01, 2024 | 204.37 | 204.73 | 202.32 | 203.55 | 4.494M |
| Oct 31, 2024 | 201.97 | 207.32 | 201.42 | 203.87 | 8.829M |
| Oct 30, 2024 | 191.62 | 202.35 | 188.54 | 201.50 | 10.40M |
| Oct 29, 2024 | 190.49 | 191.16 | 188.52 | 189.45 | 6.132M |
| Oct 28, 2024 | 188.09 | 190.14 | 187.52 | 189.68 | 5.384M |
| Oct 25, 2024 | 189.68 | 189.88 | 187.17 | 187.85 | 4.018M |
| Oct 24, 2024 | 188.43 | 190.47 | 188.17 | 189.65 | 6.742M |
| Oct 23, 2024 | 188.70 | 189.27 | 187.50 | 187.88 | 4.267M |
| Oct 22, 2024 | 186.32 | 189.10 | 186.23 | 188.76 | 4.210M |
| Oct 21, 2024 | 188.71 | 189.38 | 185.89 | 186.54 | 4.497M |
| Oct 18, 2024 | 188.97 | 189.69 | 188.16 | 188.86 | 5.608M |
| Oct 17, 2024 | 190.54 | 191.62 | 188.46 | 188.57 | 4.419M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
64.50
Minimum
Mar 23 2020
203.87
Maximum
Oct 31 2024
133.64
Average
139.55
Median
Sep 14 2022
Price Benchmarks
| Amgen Inc | 289.88 |
| Johnson & Johnson | 155.50 |
| Eli Lilly and Co | 749.91 |
| Merck & Co Inc | 99.85 |
| Pfizer Inc | 25.14 |
Price Related Metrics
| PE Ratio | 59.62 |
| PS Ratio | 5.482 |
| Price to Book Value | 50.30 |
| Price to Free Cash Flow | 19.49 |
| Earnings Yield | 1.68% |
| Market Cap | 303.42B |
| Operating PE Ratio | 20.98 |
| Normalized PE Ratio | 54.42 |